IL92167A - תכשיר המכיל אקטיבין ו/או אינהיבין - Google Patents
תכשיר המכיל אקטיבין ו/או אינהיביןInfo
- Publication number
- IL92167A IL92167A IL9216789A IL9216789A IL92167A IL 92167 A IL92167 A IL 92167A IL 9216789 A IL9216789 A IL 9216789A IL 9216789 A IL9216789 A IL 9216789A IL 92167 A IL92167 A IL 92167A
- Authority
- IL
- Israel
- Prior art keywords
- inhibin
- chain
- activin
- globin
- composition according
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/266,421 US4997815A (en) | 1988-11-01 | 1988-11-01 | Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin |
Publications (2)
Publication Number | Publication Date |
---|---|
IL92167A0 IL92167A0 (en) | 1990-07-12 |
IL92167A true IL92167A (he) | 1994-07-31 |
Family
ID=23014518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9216789A IL92167A (he) | 1988-11-01 | 1989-10-31 | תכשיר המכיל אקטיבין ו/או אינהיבין |
Country Status (9)
Country | Link |
---|---|
US (1) | US4997815A (he) |
EP (2) | EP0367590B1 (he) |
JP (1) | JPH02256622A (he) |
AT (1) | ATE119396T1 (he) |
CA (1) | CA2001897A1 (he) |
DE (1) | DE68921546T2 (he) |
IL (1) | IL92167A (he) |
MA (1) | MA21667A1 (he) |
PT (1) | PT92174B (he) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03173805A (ja) * | 1989-09-11 | 1991-07-29 | Ajinomoto Co Inc | 卵分割促進剤 |
US5166190A (en) * | 1990-01-08 | 1992-11-24 | Genentech, Inc. | Method for increasing fertility in males |
US5102868A (en) * | 1990-01-08 | 1992-04-07 | Genentech, Inc. | Method for inhibiting follicular maturation |
US5942220A (en) * | 1990-03-16 | 1999-08-24 | Chiron Corporation | Inhibitor of cytokine activity and applications thereof |
EP0515494A1 (en) * | 1990-02-15 | 1992-12-02 | Chiron Corporation | Use of inhibitor of cytokine activity |
WO1992004913A1 (en) * | 1990-09-13 | 1992-04-02 | Children's Hospital Medical Center Of Northern California | Method for increasing red blood cell production by treatment with activin or activin-related peptides |
US7910624B1 (en) | 1995-03-03 | 2011-03-22 | The Trustees Of Boston University | Compositions for the treatment of blood disorders |
WO1995005161A1 (en) * | 1993-08-13 | 1995-02-23 | Vitaphore Corporation | Hydrogel-based microsphere drug delivery systems |
US5487895A (en) * | 1993-08-13 | 1996-01-30 | Vitaphore Corporation | Method for forming controlled release polymeric substrate |
CA2174737C (en) * | 1993-10-29 | 2008-04-22 | Douglas V. Faller | Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
US5700640A (en) * | 1994-09-16 | 1997-12-23 | Basf Aktiengesellschaft | Inducers of gamma globin gene expression and screening assays therefor |
US5545616A (en) * | 1994-09-22 | 1996-08-13 | Genentech, Inc. | Method for predicting and/or preventing preterm labor |
US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
GB2306481A (en) * | 1995-10-21 | 1997-05-07 | Univ Manchester | Pharmaceutical comprising a stimulator of activin and/or inhibin |
AU3889197A (en) | 1996-07-26 | 1998-02-20 | Douglas V Faller | Compositions comprising an inducing agent and an anti-viral agent for the treat ment of blood, viral and cellular disorders |
AUPO638897A0 (en) * | 1997-04-23 | 1997-05-22 | Monash University | Modulation of cell growth and methods relating thereto |
US6822267B1 (en) * | 1997-08-20 | 2004-11-23 | Advantest Corporation | Signal transmission circuit, CMOS semiconductor device, and circuit board |
WO1999040883A2 (en) * | 1998-02-11 | 1999-08-19 | Faller Douglas V | Compositions and methods for the treatment of cystic fibrosis |
US20060003446A1 (en) * | 2002-05-17 | 2006-01-05 | Gordon Keller | Mesoderm and definitive endoderm cell populations |
AU2012203441B2 (en) * | 2002-05-17 | 2015-01-29 | Mount Sinai School Of Medicine Of New York University | Mesoderm and definitive endoderm cell populations |
AU2003304106C1 (en) * | 2002-05-17 | 2010-10-28 | Mount Sinai School Of Medicine Of New York University | Mesoderm and definitive endoderm cell populations |
US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
KR20050122210A (ko) | 2003-03-17 | 2005-12-28 | 다케다 샌디에고, 인코포레이티드 | 히스톤 탈아세틸화 효소 억제제 |
WO2005066151A2 (en) * | 2003-12-19 | 2005-07-21 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US20050159470A1 (en) * | 2003-12-19 | 2005-07-21 | Syrrx, Inc. | Histone deacetylase inhibitors |
US20060040868A1 (en) * | 2004-08-10 | 2006-02-23 | Bowen Richard L | Methods for treating premature infants |
US7642275B2 (en) * | 2004-12-16 | 2010-01-05 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
EP1896436A2 (en) * | 2005-05-11 | 2008-03-12 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
CN101263121A (zh) * | 2005-07-14 | 2008-09-10 | 塔克达圣地亚哥公司 | 组蛋白脱乙酰基酶抑制剂 |
EP1976835A2 (en) * | 2006-01-13 | 2008-10-08 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
US8874380B2 (en) | 2010-12-09 | 2014-10-28 | Rutgers, The State University Of New Jersey | Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs |
WO2010105112A1 (en) * | 2009-03-11 | 2010-09-16 | Hemaquest Pharmaceuticals, Inc. | Detection of short-chain fatty acids in biological samples |
US20110086869A1 (en) | 2009-09-24 | 2011-04-14 | The Trustees Of Boston University | Methods for treating viral disorders |
EP2509418A4 (en) | 2009-12-08 | 2013-03-20 | Hemaquest Pharmaceuticals Inc | METHODS AND REGIMES AT LOW DOSE FOR TREATING RED GLOBULAR DISORDERS |
WO2011113013A2 (en) | 2010-03-11 | 2011-09-15 | Hemaquest Pharmaceuticals, Inc. | Methods and compositions for treating viral or virally-induced conditions |
US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
US9724396B2 (en) | 2013-03-15 | 2017-08-08 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
WO2016064815A1 (en) * | 2014-10-20 | 2016-04-28 | Massachusetts Institute Of Technology | Functional ghrelin receptor antagonism during pregnancy to prevent stress-associated mental illness in offspring and mothers |
WO2016138099A1 (en) | 2015-02-24 | 2016-09-01 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
AU2020283590A1 (en) | 2019-05-31 | 2022-01-20 | Viracta Subsidiary, Inc. | Methods of treating virally associated cancers with histone deacetylase inhibitors |
MX2024004801A (es) | 2021-10-19 | 2024-06-28 | Akirabio Inc | Composiciones que comprenden análogos de 2'- desoxicitidina, y uso de las mismas para el tratamiento de anemia de células falciformes, talasemia y cánceres. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0730114B2 (ja) * | 1985-04-03 | 1995-04-05 | 正雄 五十嵐 | インヒビン |
JPH0637520B2 (ja) * | 1985-07-03 | 1994-05-18 | 味の素株式会社 | ポリペプチド |
US4740587A (en) * | 1985-07-18 | 1988-04-26 | The Salk Institute For Biological Studies | Inhibin and method of purifying same |
NZ217727A (en) * | 1985-10-03 | 1990-05-28 | Genentech Inc | Nucleic acid encoding alpha or b chain of inhibin, its production and compositions containing it |
NZ217821A (en) * | 1985-10-10 | 1989-07-27 | Biotech Australia Pty Ltd | Oral delivery system; complex of active agent and vitamin b12 or analogue thereof |
US4822821A (en) * | 1986-10-10 | 1989-04-18 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin |
AU610858B2 (en) * | 1987-01-29 | 1991-05-30 | Inhibin Pty Limited | Isolation of single chain proteins with fsh suppressing activity from follicular fluid |
GB2209937B (en) * | 1987-09-21 | 1991-07-03 | Depiopharm S A | Water insoluble polypeptides |
US5032507A (en) * | 1987-11-13 | 1991-07-16 | The Salk Institute For Biological Studies | Potentiation of erythropoiesis |
-
1988
- 1988-11-01 US US07/266,421 patent/US4997815A/en not_active Expired - Fee Related
-
1989
- 1989-10-31 CA CA002001897A patent/CA2001897A1/en not_active Abandoned
- 1989-10-31 IL IL9216789A patent/IL92167A/he not_active IP Right Cessation
- 1989-10-31 MA MA21919A patent/MA21667A1/fr unknown
- 1989-11-01 JP JP1286002A patent/JPH02256622A/ja active Pending
- 1989-11-01 EP EP89311297A patent/EP0367590B1/en not_active Expired - Lifetime
- 1989-11-01 DE DE68921546T patent/DE68921546T2/de not_active Expired - Fee Related
- 1989-11-01 EP EP94200748A patent/EP0617966A1/en not_active Withdrawn
- 1989-11-01 AT AT89311297T patent/ATE119396T1/de active
- 1989-11-02 PT PT92174A patent/PT92174B/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US4997815A (en) | 1991-03-05 |
PT92174A (pt) | 1990-05-31 |
DE68921546D1 (de) | 1995-04-13 |
JPH02256622A (ja) | 1990-10-17 |
PT92174B (pt) | 1995-09-12 |
EP0367590A2 (en) | 1990-05-09 |
EP0367590B1 (en) | 1995-03-08 |
CA2001897A1 (en) | 1990-05-01 |
IL92167A0 (en) | 1990-07-12 |
EP0367590A3 (en) | 1992-01-02 |
MA21667A1 (fr) | 1990-07-01 |
ATE119396T1 (de) | 1995-03-15 |
EP0617966A1 (en) | 1994-10-05 |
DE68921546T2 (de) | 1995-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4997815A (en) | Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin | |
US5216004A (en) | Method for preventing malaria | |
EP0548276A4 (en) | Method for increasing red blood cell production by treatment with activin or activin-related peptides | |
US5646113A (en) | Treatment of partial growth hormone insensitivity syndrome | |
US5126324A (en) | Method of enhancing growth in patients using combination therapy | |
AU655059B2 (en) | Method of stimulating immune response | |
US4699897A (en) | Biologically active peptides structurally related to regions within growth hormones | |
US5681814A (en) | Formulated IGF-I Composition | |
US20090088380A1 (en) | Ghrh analogs and therapeutic uses thereof | |
CA2185998C (en) | The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure | |
AU2003229222B2 (en) | GRF analog compositions and their use | |
US5824642A (en) | Treatment of partial growth hormone insensitivity syndrome | |
US6207640B1 (en) | Treatment of partial growth hormone insensitivity syndrome | |
Fatouros et al. | Alterations in body weight, breaking strength, and wound healing in Wistar rats treated pre-and postoperatively with erythropoietin or granulocyte macrophage–colony stimulating factor: Evidence of a previously unknown anabolic effect of erythropoietin? | |
JPH08502969A (ja) | 肥満の予防または治療方法 | |
US20210008164A1 (en) | Erythropoietin for Gastrointestinal Dysfunction | |
Cotes | Erythropoietin: the developing story | |
US5317012A (en) | Human growth hormone induced improvement in depressed T4/T8 ratio | |
WO1999049894A1 (en) | Antagonists to growth arrest specific gene 6 to treat insulin-resistant disorders | |
Baumann | Molecular heterogeneity of circulating growth hormone in acromegaly | |
MXPA98009140A (en) | Treatment of the partial insensitivity syndrome to the growth hormone | |
JPH03505088A (ja) | ホルモン類の作用 | |
MXPA96004802A (en) | Treatment of cardiac failure congest |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |